Results 31 to 40 of about 5,941 (179)

Tenecteplase Versus Alteplase in Medium Vessel Occlusion Ischemic Stroke: A Secondary Analysis of the Alteplase Compared to Tenecteplase Randomized Trial [PDF]

Journal of Stroke
Background and Purpose The safety and efficacy of tenecteplase in patients with ischemic stroke due to medium vessel occlusion (MeVO) are not well studied. We aimed to compare tenecteplase with alteplase in stroke due to MeVO.
Fouzi Bala, Nishita Singh, Katrina Ignacio, Ibrahim Alhabli, Ayoola Ademola, Anas Alrohimi, Houman Khosravani, Aleksander Tkach, Luciana Catanese, Dariush Dowlatshahi, Thalia Field, Gary Hunter, Faysal Benali, MacKenzie Horn, Andrew Demchuk, Michael Hill, Tolulope Sajobi, Brian Buck, Richard Swartz, Mohammed Almekhlafi, Bijoy K. Menon   +20 more
doaj   +1 more source

Fixed low-dose ultrasound-assisted catheter-directed thrombolysis for intermediate and high-risk pulmonary embolism [PDF]

, 2017
Aims No standardized local thrombolysis regimen exists for the treatment of pulmonary embolism (PE). We retrospectively investigated efficacy and safety of fixed low-dose ultrasound-assisted catheter-directed thrombolysis (USAT) for intermediate- and ...
Baumann, Frederic, Baumgartner, Iris, Diehm, Nicolas, Do, Do-Dai, Engelberger, Rolf P., Fahrni, Jennifer, Kucher, Nils, Moschovitis, Aris, Willenberg, Torsten   +8 more
core  

ST2 in Stable and Unstable Ischemic Heart Diseases [PDF]

, 2015
Circulating suppression of tumorigenicity 2 (ST2) predicts cardiovascular outcomes and mortality in ischemic heart disease (IHD). ST2 does not correlate with traditional risk indicators as closely as N-terminal pro–brain natriuretic peptide (NT-proBNP ...
DI SOMMA, Salvatore, Mueller, T., Richards, Am   +2 more
core   +1 more source

Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the umbrella phase IIa CHABLIS-T randomised clinical trial

Stroke and Vascular Neurology
Background The performance of intravenous tenecteplase in patients who had an acute ischaemic stroke with large/medium vessel occlusion or severe stenosis in an extended time window remains unknown.
Yilong Wang, Qiang Dong, Yi Sui, Leonid Churilov, Gang Li, Xiaoyu Zhou, Jin Zhang, Yu Geng, Hong-Qiu Gu, Danhong Wu, Longting Lin, Ying Guo, Xiaofei Yu, Mark Parsons, Yuwu Zhao, Yangmei Chen, Xin Cheng, Lumeng Yang, Jianhong Yang, Lan Hong, Yifeng Ling, Xueyuan Liu, Qijin Zhai, Liandong Zhao, Fan Gong   +24 more
doaj   +1 more source

Real-world comparative safety and efficacy of tenecteplase alteplase in acute ischemic stroke patients with large vessel occlusion

Therapeutic Advances in Neurological Disorders, 2021
Background and aims: Tenecteplase has recently emerged as an alternative thrombolytic agent in acute ischemic stroke (AIS) patients with large vessel occlusion (LVO), possibly superior in achieving early reperfusion compared with alteplase.
Klearchos Psychogios, Lina Palaiodimou, Aristeidis H. Katsanos, Georgios Magoufis, Apostolos Safouris, Odysseas Kargiotis, Stavros Spiliopoulos, Ermioni Papageorgiou, Aikaterini Theodorou, Konstantinos Voumvourakis, Elias Broutzos, Elefterios Stamboulis, Georgios Tsivgoulis   +12 more
doaj   +1 more source

Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis [PDF]

, 2017
Aim Thrombolytic therapy induces faster clot dissolution than anticoagulation in patients with acute pulmonary embolism (PE) but is associated with an increased risk of haemorrhage.
Combescure, Christophe, John, Gregor, Konstantinides, Stavros, Lankeit, Mareike, Marti, Christophe, Meyer, Guy, Perrier, Arnaud, Sanchez, Olivier   +7 more
core  

Editor's choice : European Society for Vascular Surgery (ESVS) 2020 clinical practice guidelines on the management of acute limb ischaemia

, 2020
A
Acosta, Stefan, Azuma, Nobuyoshi, Bastos Gonçalves, Frederico, Björck, Martin, Boyle, Jonathan R., Chakfé, Nabil, Choke, Edward T. C., Cochennec, Frederic, Cohnert, Tina U., de Borst, Gert J., Document Reviewers, Earnshaw, Jonothan J., ESVS Guidelines Committee, Fitridge, Robert A., Forbes, Thomas L., Hamady, Mohamad S., Hinchliffe, Robert, Jongkind, Vincent, Kakkos, Stavros K., Koelemay, Mark J. W., Koncar, Igor, Lindholt, Jes S., Mani, Kevin, Menyhei, Gabor, Munoz, Alberto, Müller-Hülsbeck, Stefan, Rai, Kumud, Sebastian Debus, E., Svetlikov, Alexei V., Tshomba, Yamume, Tulamo, Riikka, van den Berg, Jos C., Vega de Ceniga, Melina, Vermassen, Frank   +33 more
core   +2 more sources

The safety of enoxaparine use in elderly with acute myocardial infarction [PDF]

, 2007
Background/Aim. Enoxaparin (ENOX), the lowmolecular- weight heparin, used in acute myocardial infarction (AMI) could lead to hemorrhage. The aim of this study was to determine whether bleeding was more often in AMI patients older than 65 or 75 years who ...
Despotović Nebojša, Dimković Siniša, Ilić Marjan, Lončar Goran, Nikolić-Despotović Maja   +4 more
core   +1 more source

Efficacy and safety of tenecteplase for acute ischemic stroke within an extended treatment window: a systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials [PDF]

Journal of Neurocritical Care
Background In acute ischemic stroke (AIS), the treatment window for thrombolytics is 4.5 hours from symptom onset. Tenecteplase, a modified tissue plasminogen activator, may be effective over an extended treatment window (4.5–24 hours).
Hesham Kelani, Mohamed R. Abdelraouf, Hazem Mohamed Salamah, Eli Berglas, Toka Elboraay, Abdelrahman Mahmoud, Mohamed Abugdida, Nadia Albaramony, Ahmed Abd Elazim, Diana Greene-Chandos, Mohammad El-Ghanem, Volodymyr Vulkanov, Artem Sunik, Amit Khaneja, David P. Lerner, Fawaz Al-Mufti   +15 more
doaj   +1 more source

Pneumonitis and pulmonary haemorrhage after acute myocardial infarction [PDF]

, 2015
A 55-year-old man presented with acute ST-elevation myocardial infarction. He received rescue angioplasty with one drug eluting stent. He developed marked breathlessness and haemoptysis two days later.
Millar, Colin GM, Noman, Awsan, Parasuraman, Sathish K, Teo, Alison IC   +3 more
core   +1 more source